	Beyond diagnosis: exploring the extended clinical utility of urine fluorescence in situ hybridization in upper tract urothelial carcinoma. BMC Urol Zhao Y, Zhang N, Zhang S, Zhang X, Liu L, Chen J. PMID: 41423684 [PubMed - as supplied by publisher]
	Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer center. BMC Cancer Sundaramoorthy S, Abraham G, Narayanan G, Nair SG, Purushothaman PN, Thambi SM, Mathew SP, Philip DSJ, Nair S, Muthukumarasamy T. PMID: 41423670 [PubMed - as supplied by publisher]
	Multi-omics integration and machine learning define robust molecular subtypes and prognostic signatures in hepatocellular carcinoma. J Transl Med Wang X, Yan B, Yang J, Cheng Z, Song W, Yang Y, Wang J. PMID: 41423668 [PubMed - as supplied by publisher]
	Neoadjuvant serplulimab combined with chemotherapy for resectable oesophageal squamous cell carcinoma: a single-arm, phase 2 trial. Nat Commun Wu Z, Wu C, Wang Y, Liang F, Qi L, Wang K, Shen G, Li J, Shen H, Wu M. PMID: 41423619 [PubMed - as supplied by publisher]
	Antibiotic use and survival from breast cancer: A population-based cohort study in England and Wales. Nat Commun Cardwell CR, Baxter SM, Snelling AJ, Chen DT, Atakpa EC, McMenamin Ú, McIntosh SA, Hicks B, Coupland CA, Brady AJ, Bannon FJ, Hippisley-Cox J. PMID: 41423616 [PubMed - as supplied by publisher]
	The crosstalk of m6A modification and non-coding RNAs in gastric cancer: biomarkers and therapeutic potentials. Cancer Cell Int Li P, Xue Y, Gu X. PMID: 41423606 [PubMed - as supplied by publisher]
	Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study. Breast Cancer Res Bhave M, Jhaveri KL, Kaufman PA, Aftimos P, Lombard J, Giridhar KV, Im SA, Ma CX, Lee KT, Kim SB, Sohn J, Li Y, Yuen E, Estrem ST, Nguyen B, Makena MR, Ismail-Khan R, Beeram M. PMID: 41423595 [PubMed - as supplied by publisher]
	The incidence of a second primary cancer diagnosis and impact on health-related quality of life in Black cancer survivors. J Cancer Surviv Ruterbusch JJ, Cooney KA, Baird TE, Lusk C, Dyson G, Wenzlaff A, Snyder N, Shevach J, Schwartz AG, Beebe-Dimmer JL. PMID: 41423586 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Surgical Management and Outcomes in Pediatric Adrenocortical Carcinoma: A Pediatric Surgical Oncology Research Collaborative Study. Ann Surg Oncol Srivatsa S, Aldrink JH, Haque MR, Murphy A, Gehle D, Halepota H, Newman EA, Williams K, Mattei P, Johnston WR, Hwang R, Lautz TB, Ayala SA, Piché N, Lemoine CP, Debertin J, Polites SF, Rothstein DH, Riehle KJ, Nchinda N, Malek MM, Rinehardt HN, Gestrich C, Castle SL, Lopez A, Mayes MS, Myers EK, Roach JP, Craig BT, Lal DR, Schuh J, Cromeens BP, Mannava SV, Austin MT, Mayon LK, Kastenberg ZJ, Wallace M, Alexander A, Stellon MA, Le HD, Joshi DS, Chidiac C, Rhee DS, Cameron D, Stetson A, Rich BS, Glick RD, Fialkowski EA, Fowler K, Fareh R, Brown EG, Doyle K, Abril P, Grant C, Dasgupta R, Boehmer C, Mansfield SA. PMID: 41423574 [PubMed - as supplied by publisher]
	Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming. J Egypt Natl Canc Inst Adusumalli R, Banala RR. PMID: 41423542 [PubMed - in process]
	Significant clinical and radiologic response to targeted therapy in pediatric cervicomedullary low-grade gliomas harboring the BRAFV600E mutation. Childs Nerv Syst Campino GA, Shrot S, Constantini S, Roth J, Toren A, Lurye M, Yalon-Oren M. PMID: 41423525 [PubMed - indexed for MEDLINE]
	High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group. Br J Cancer Jansson AK, Cohn-Cedermark G, Negaard HFS, Tandstad T, Ståhl O, Hedlund A, Karlsdottir Å, Hellström M, Langberg CW, Sköld C, Haugnes HS, Glimelius I. PMID: 41423507 [PubMed - as supplied by publisher]
	High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD). Br J Cancer Nair-Shalliker V, Smith DP, Gebski V, Patel MI, Frydenberg M, Yaxley J, Gardiner R', Espinoza D, Kimlin MG, Dhillon V, Leifert W, Gillatt D, Woo H, Rasiah K, Awad N, Symons J, Wells JK, Pickett HA, Fenech M, Anderson PH, Armstrong BK, Gurney H. PMID: 41423505 [PubMed - as supplied by publisher]
	Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial. Nat Commun Wu X, Wang J, Wang D, Li G, Zhang J, Chen H, Yang H, Zhou Q, Wang K, Wu Y, Yi T, Liu J, Huang Y, Bai Y, Wang K, Jiang K, Lou H, An R, Li X, Pan Y, Wang Y, Tao W, Song K, Kang Y, Li Y, Shi W, Liu A, Yang Y, Wang Y, Chen K, Shi H, Lu P, Tan P, Fan S, Shi M, Su W. PMID: 41423492 [PubMed - as supplied by publisher]
	Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse Events. Cancer Med Obeng-Kusi M, De Nigris E, Leng S, Farooqui MZH, Yapici HO, Weimer I, Jiao W, Hyatt HW, Zhang X, Lodaya K, Dingli D. PMID: 41423437 [PubMed - indexed for MEDLINE]
	Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based Studies. Cancer Med Stock SR, Parrish JA, Burns MT, Janes JL, Waller J, De Hoedt AM, Ghate S, Kim J, Shui IM, Freedland SJ. PMID: 41423433 [PubMed - indexed for MEDLINE]
	CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study. Cancer Med Yang J, Wang L, Zhu M, Xiang X, Wu Y, Niu T, Gong Y, Chen X, He C, Dai Y, Shuai X, Ma H. PMID: 41423432 [PubMed - indexed for MEDLINE]
	Research Progress on the Prognostic Significance of Systemic Immune Inflammation Index in Patients With Resected Colorectal Cancer: A Meta-Analysis. Geriatr Gerontol Int Sati DM, Maqsood R, Sonje PD, Paul JR. PMID: 41423419 [PubMed - in process]
	Targeting Î³Î´ T cells for immunotherapies against colorectal cancer. Trends Immunol Mikulak J, Marzano P, Cazzetta V, Mavilio D. PMID: 41423387 [PubMed - as supplied by publisher]
	IL-11 as a potential diagnostic and prognostic biomarker in oral submucous fibrosis-related oral squamous cell carcinoma: A single-center exploratory study. J Craniomaxillofac Surg Liu Y, Quan H. PMID: 41423377 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1896349

Page 1 of 94818



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy